LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$63 | -$6 | -$14 |
| Dep. & Amort. | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $0 | $0 |
| Change in WC | $3 | -$1 | $0 |
| Other Non-Cash | $3 | -$5 | $11 |
| Operating Cash Flow | -$53 | -$12 | -$3 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$1 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$30 | -$34 | $0 |
| Inv. Sales/Matur. | $54 | $6 | $0 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | $23 | -$28 | $0 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $1 | $25 |
| Stock Issued | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $38 | $33 | -$2 |
| Financing Cash Flow | $38 | $34 | $23 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $8 | -$6 | $20 |
| Supplemental Information | – | – | – |
| Beg. Cash | $15 | $21 | $1 |
| End Cash | $23 | $15 | $21 |
| Free Cash Flow | -$54 | -$12 | -$3 |